ÂÜÀòÂÒÂ×

Julien Peltier is currently working as a Principal Scientist at Inoviv since December 2021. Previously, Julien held positions at GSK as an Investigator from January 2019 to December 2021, at Newcastle University and The University of Dundee as a Postdoctoral Research Associate in Matthias Trost Lab, and at Aix-Marseille Université where Julien completed their PhD in Oncology. Julien holds a Doctor of Philosophy (PhD) in Oncology from Aix-Marseille University, a Master's degree in Structural biology & functional proteomic from Paris-Sud University (Paris XI), and a Bachelor's degree in Biochemistry from Université de Rouen.